Abbott Labs to Pay $1.5 Billion for Unapproved Marketing

The pharmaceutical company will pay $1.5 billion to settle criminal and civil liability charges for promoting the drug Depakote for uses not approved by the Food and Drug Administration.
The drug is a neurological medicine labeled to treat mania, epilepsy and migraines, and can lead to life-threatening and deadly pancreatitis in children and adults.
The money will be distributed among 49 states and will go toward consumer protection, health care and other services. –ARK
Wait, before you go…The Epoch Times:
According to DOJ, Abbott Labs maintained a specialized sales force to market the drug for such purposes, targeting elderly dementia patients in nursing homes.
“Under the Food, Drug, and Cosmetic Act (FDCA), a company in its application to the FDA must specify each intended use of a drug. A company’s promotional activities must be limited to only the intended uses that FDA approved. In fact, promotion by the manufacturer for other uses — known as ‘off-label’ uses — renders the product misbranded,” states the press release.
The settlement is the second-largest payment ever made by a drug company. It includes a criminal fine and forfeiture totaling $700 million, as well as civil settlements with the federal government and 49 states, including the District of Columbia, totaling $800 million.
If you're reading this, you probably already know that non-profit, independent journalism is under threat worldwide. Independent news sites are overshadowed by larger heavily funded mainstream media that inundate us with hype and noise that barely scratch the surface. We believe that our readers deserve to know the full story. Truthdig writers bravely dig beneath the headlines to give you thought-provoking, investigative reporting and analysis that tells you what’s really happening and who’s rolling up their sleeves to do something about it.
Like you, we believe a well-informed public that doesn’t have blind faith in the status quo can help change the world. Your contribution of as little as $5 monthly or $35 annually will make you a groundbreaking member and lays the foundation of our work.
Support Truthdig
There are currently no responses to this article.
Be the first to respond.